Episode
Why Private Equity Is Buying Up Hearing Aid Dispensaries
- Published
- Jul 5, 2026
- Duration seconds
- 645
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-buyout-show-with-fexingo-private-equity-roll-ups-and-business-acquisitions-7871630/episodes/why-private-equity-is-buying-up-hearing-aid-dispensaries/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-buyout-show-with-fexingo-private-equity-roll-ups-and-business-acquisitions-7871630/why-private-equity-is-buying-up-hearing-aid-dispensaries.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Lucas and Luna dive into a surprising roll-up target: hearing aid dispensaries. With the OTC hearing aid rule from 2022 finally reshaping the market, private equity sees a fragmented $8 billion industry ripe for consolidation. They break down how firms like Audibel and HearingLife are being acquired by larger platforms, the demographics driving demand, and why the average cost of a pair of hearing aids—$4,600—creates both opportunity and scrutiny. A focused look at what happens when PE meets audiology. #PrivateEquity #HearingAids #HealthcareInvesting #RollUp #Audibel #HearingLife #OTCHeaingAids #Demographics #Consolidation #BusinessAcquisition #HealthcareRollUp #FexingoBusiness #BusinessPodcast #TheBuyoutShow #Audiology #SilverEconomy #HealthcarePE #MergerAndAcquisition Keep every episode free: buymeacoffee.com/fexingo